PharmaCyte Biotech, Inc.PMCBNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank79
Year-over-Year Change
Year-over-year research & development expense growth
Latest
7.60%
↑ 217% vs avg
Percentile
P79
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
2.40%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 7.60% |
| 2024 | -13.04% |
| 2023 | -32.19% |
| 2022 | -24.59% |
| 2021 | 204.18% |
| 2020 | -34.52% |
| 2019 | -76.97% |
| 2018 | 69.04% |
| 2017 | -15.99% |
| 2016 | -59.53% |